MLL3 and MLL4 are coactivators of p53 and act as tumor suppressors by labeling H3K4me3 to express endogenous p53-target genes induced by DNA-damaging agents, such as doxorubicin [128]. The gene discussed is KMT2C; the disease is neoplasm.